Switch to:
Horizon Pharma PLC (NAS:HZNP)
EV/EBITDA
126.29 (As of Today)

EV/EBITDA ratio is calculated as enterprise value divided by its EBITDA. As of today, Horizon Pharma PLC's enterprise value is $5,257.0 Mil. Horizon Pharma PLC's earnings before depreciation and amortization for the trailing twelve months (TTM) ended in Mar. 2015 was $41.6 Mil. Therefore, Horizon Pharma PLC's EV/EBITDA ratio for today is 126.29.

EV/EBITDA (Enterprise value/EBITDA) is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the P/E Ratio to determine the fair market value of a company.

As of today, Horizon Pharma PLC's stock price is $33.86. Horizon Pharma PLC's earnings per share for the trailing twelve months (TTM) ended in Mar. 2015 was $-0.79. Therefore, Horizon Pharma PLC's P/E Ratio for today is .

The "classic" EV/EBITDA ratio is much better in capturing debt and net cash than the P/E Ratio.


Definition

Horizon Pharma PLC's EV/EBITDA for today is calculated as:

EV/EBITDA=Enterprise Value (Today)/Earnings Before Depreciation and Amortization (TTM)
=5257.040/41.627
=126.29

Horizon Pharma PLC's current Enterprise Value is $5,257.0 Mil.
Horizon Pharma PLC's Earnings Before Depreciation and Amortization for the trailing twelve months (TTM) ended in Mar. 2015 was -1.667 (Jun. 2014 ) + -5.135 (Sep. 2014 ) + 25.33 (Dec. 2014 ) + 23.099 (Mar. 2015 ) = $41.6 Mil.

* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.


Explanation

EV/EBITDA (Enterprise value/EBITDA) is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the P/E Ratio to determine the fair market value of a company.

Horizon Pharma PLC's P/E Ratio for today is calculated as:

P/E Ratio=Share Price (Today)/Earnings Per Share (TTM)
=33.86/-0.794
=

Horizon Pharma PLC's share price for today is $33.86.
Horizon Pharma PLC's Earnings Per Share for the trailing twelve months (TTM) ended in Mar. 2015 was -0.38 (Jun. 2014 ) + 0.02 (Sep. 2014 ) + -0.274 (Dec. 2014 ) + -0.16 (Mar. 2015 ) = $-0.79.

* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.

Study has found that the companies with the lowest EV/EBITDA outperforms companies measured as cheap by other ratios such as P/E Ratio.

Please read Which price ratio outperforms the enterprise multiple?


Related Terms

Enterprise Value, Earnings Before Depreciation and Amortization, P/E Ratio


Historical Data

* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.

Horizon Pharma PLC Annual Data

Dec08Dec09Dec10Dec11Dec12Dec13Dec14
ev2ebitda 0.000.000.000.000.000.00-0.69-1.21-15.9267.62

Horizon Pharma PLC Quarterly Data

Dec12Mar13Jun13Sep13Dec13Mar14Jun14Sep14Dec14Mar15
ev2ebitda -1.21-1.92-1.98-4.04-15.92-104.06511.09-696.4367.6284.25
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GuruFocus Premium Plus Membership

FEEDBACK